收藏切换
Research progress on the regulation of mitochondrial dysfunction by traditional Chinese medicine in the intervention of Parkinson’s disease
收藏切换
PDF
Jian-qing LIANG1, 2, Zi-wei LÜ3, Jian-cheng HE4
Chinese Journal of Clinical Pharmacology | 2025, 41(17) : 2526 - 2533
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(17): 2526-2533
Review
Research progress on the regulation of mitochondrial dysfunction by traditional Chinese medicine in the intervention of Parkinson’s disease
Full
Jian-qing LIANG1, 2, Zi-wei LÜ3, Jian-cheng HE4
Affiliations
  • 1.School of Basic Medical Sciences, Gansu University of Chinese Medicine, Lanzhou 730101, Gansu Province, China
  • 2.Key Laboratory of Dunhuang Medicine and Transformation, Lanzhou 730000, Gansu Province, China
  • 3.Shangqiu Institute of Technology, Shangqiu 476000, Henan Province, China
  • 4.School of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Published: 2025-09-17 doi: 10.13699/j.cnki.1001-6821.2025.17.022
Outline
收藏切换

With China’s transition into an aging society, Parkinson’s disease (PD) has emerged as the second most prevalent neurodegenerative disorder threatening the health of the elderly population. However, there is still a lack of ideal clinical drugs that can effectively treat PD or halt its progression. Mitochondrial dysfunction is one of the key pathogenic mechanisms underlying PD, involving abnormalities in energy metabolism, mitophagy, oxidative stress, calcium homeostasis, mitochondrial dynamics and apoptosis. In recent years, traditional Chinese medicine (TCM) has demonstrated promising efficacy in treating PD by targeting mitochondrial function. Based on the critical role of mitochondrial dysfunction in PD pathogenesis, this article focuses on the research progress of TCM monomers and compound formulations in intervening PD by regulating pathways related to mitochondrial dysfunction. The aim is to provide a theoretical foundation and novel insights for further research into TCM-based mitochondrial-targeted therapies for PD.

monomer of Chinese traditional herbs  /  traditional Chinese medicine formula  /  Parkinson’s disease  /  mitochondrial dysfunction  /  research status
Jian-qing LIANG, Zi-wei LÜ, Jian-cheng HE. Research progress on the regulation of mitochondrial dysfunction by traditional Chinese medicine in the intervention of Parkinson’s disease[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (17) : 2526 -2533 . DOI: 10.13699/j.cnki.1001-6821.2025.17.022
Year 2025 volume 41 Issue 17
PDF
160
34
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.17.022
  • Receive Date:2025-04-25
  • Online Date:2026-08-05
  • Published:2025-09-17
Article Data
Affiliations
History
  • Received:2025-04-25
Funding
Affiliations
    1.School of Basic Medical Sciences, Gansu University of Chinese Medicine, Lanzhou 730101, Gansu Province, China
    2.Key Laboratory of Dunhuang Medicine and Transformation, Lanzhou 730000, Gansu Province, China
    3.Shangqiu Institute of Technology, Shangqiu 476000, Henan Province, China
    4.School of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.17.022
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT